GoodRx Holdings (GDRX) Debt/EBITDA US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
Debt/EBITDA 1.03 -4.97 -10.6 -0.62 0.24   1.62  
Changes by years, y/y, % -77% -585% +113% -94% -139%     -50.4%

GoodRx Holdings. Debt/EBITDA

GoodRx Holdings. Debt/EBITDA, changes, %

GoodRx Holdings (GDRX) Debt/EBITDA US GAAP (quarter values)

2023Q1 2023Q2 2023Q3 2023Q4 2024Q1   LTM ?
Debt/EBITDA -0.69 -0.49 -0.85 0.37 1.62   1.62
Changes by years, y/y, % -63% +31% +83% -160% -336%    
Changes by quarters, q/q, % +12% -29% +75% -144% +336%    

GoodRx Holdings. Debt/EBITDA

GoodRx Holdings. Debt/EBITDA, changes, y/y, %

GoodRx Holdings. Debt/EBITDA, changes, q/q, %